Liqtech International INC

LiqTech International, Inc. has received a deficiency notice from Nasdaq regarding its common stock's bid price falling below the $1 minimum requirement.

LiqTech International, Inc. has priced a public offering of 20,000,000 shares of common stock at $1.00 per share, raising approximately $20 million in gross proceeds.

LiqTech International has entered into a debt cancellation agreement to exchange $3 million of senior promissory notes for common stock alongside a concurrent public offering.

LiqTech International, Inc. has issued $1.1 million in 9.09% original discount promissory notes to affiliates of Bleichroeder L.P. and Laurence W. Lytton to fund working capital.

LiqTech International, Inc. announced that its stockholders approved an amendment to increase the shares authorized under its 2022 Equity Incentive Plan by 1,500,000 to a total of 2,500,000 shares, alongside the election of five directors and ratification of its accounting firm.

LiqTech International has appointed David Kowalczyk as its new Chief Financial Officer and Chief Operating Officer, effective March 1, 2025, while Phillip Massie Price will step down from his interim CFO role.

LiqTech International reported a 10.4% decrease in revenue for Q1 2026 compared to the prior year, but saw a significant improvement in gross profit margin due to a favorable product mix and better manufacturing utilization.

LiqTech International, Inc. reported a significant reduction in net loss for Q3 2025, driven by robust growth in liquid filtration and plastics segments.

LiqTech International, Inc. reported increased revenue for Q2 2025 and the first half of 2025, driven by liquid filtration and plastics, but faced declining gross profit margins and continued net losses, alongside ongoing internal control weaknesses and new tariff risks.

LiqTech International saw a revenue increase in Q1 2025, but gross profit decreased due to development costs and underutilization of manufacturing capacity.

LiqTech International's Q3 2024 results show a significant decrease in revenue and a widening net loss compared to the same period last year, alongside a recent capital raise to address liquidity concerns.

LiqTech International's Q2 2024 results show a net loss increase to $2.1 million, driven by a revenue decrease and unfavorable product mix.

LiqTech International, Inc. filed an amendment to its 2025 Annual Report on Form 10-K, primarily updating information on directors, executive compensation, and corporate governance.

LiqTech International, Inc. reported a 13% revenue increase and improved gross profit for fiscal year 2025, but faces substantial doubt about its ability to continue as a going concern.

LiqTech International's 2024 annual report reveals a revenue decrease of 18.9% alongside strategic efforts to enhance financial stability and market penetration.

LiqTech International has filed an amendment to its 2023 annual report, primarily to include Part III disclosures regarding directors, executive compensation, and corporate governance.

LiqTech International, Inc. reports a significant increase in gross profit for 2023, alongside a reduction in net loss, despite ongoing economic uncertainties.

Bleichroeder LP acquired 3.7 million shares of LiqTech International through a public offering and a debt-for-equity swap.

LIQTECH International CEO Chen Fei reported the withholding of 67,860 shares for tax obligations related to restricted stock unit vesting on January 3, 2026.

LiqTech International's CFO and COO, David Kowalczyk, reported the acquisition of 94,368 restricted stock units and the subsequent net settlement of 5,589 shares for tax withholding.

LiqTech International CEO Fei Chen disposed of 13,021 common shares to cover tax liabilities related to restricted stock unit vesting.

Bleichroeder LP, investment advisor to 21 April Fund, amended warrants to purchase LiqTech International stock, reducing the exercise price from $5.20 to $2.00 and extending the expiration date to December 31, 2029.

Director Alexander Buehler reported the acquisition of 53,030 shares of LiqTech International Inc. common stock on January 7, 2025, through restricted stock unit awards.

LiqTech International filed an amendment to its definitive proxy statement to include Inline XBRL data tagging for disclosures related to the company's insider trading policy and the timing of equity awards.

LiqTech International, Inc. has filed a definitive proxy statement with the SEC.

LiqTech International is holding its annual meeting to elect directors, ratify the appointment of auditors, and approve an amendment to the company's equity incentive plan.

LiqTech International is holding its annual meeting on November 8, 2024, seeking stockholder approval for director elections, auditor ratification, a stock issuance related to a securities purchase agreement, and executive compensation.

Bleichroeder LP has amended its Schedule 13D filing to reflect an increased beneficial ownership of LiqTech International, Inc. common stock to 20.9%, following a debt cancellation and exchange agreement and participation in a public offering.

Bleichroeder LP, through managed funds, has acquired $550,000 in discount promissory notes and increased its beneficial ownership of LiqTech International shares to 33.7%.

LiqTech International, Inc. has announced an agreement with its significant shareholder, Bleichroeder LP, to extend the maturity of certain Notes to May 2027 and amend existing warrants, adjusting their exercise price and expiration.

Bleichroeder LP, along with Bleichroeder Holdings LLC and Andrew Gundlach, has filed an Amendment No. 1 to their Schedule 13D, confirming beneficial ownership of 3,182,239 shares, representing 33.7% of LiqTech International, Inc.'s common stock.

Marathon Micro Fund, LP has disclosed beneficial ownership of 3,000,000 shares, representing 9.1% of the outstanding common stock of LiqTech International Inc.

Laurence W. Lytton and Lytton-Kambara Foundation reaffirm significant passive ownership in LiqTech International Inc. through an amended Schedule 13G filing.

Ben Andrews has disclosed a 9.0% beneficial ownership stake in LiqTech International Inc., holding 852,600 shares of common stock as of December 31, 2024.